Amylyx Pharmaceuticals (NasdaqGS:AMLX) FY Conference September 10, 2025 10:00 AM ET Company ParticipantsLi Chen - Equity Research AssociateJim Frates - CFOLi ChenWelcome everyone to the Investment Global Conference. My name is Li Chen. I'm an Equity Research Associate at HC Wainwright. Our next speaker is Mr. Jim Frates, CFO of Amylyx Pharmaceuticals. Amylyx is a clinical-stage biotech focusing on developing novel therapies across several neurodegenerative and endocrine diseases.Jim FratesThank you very muc ...